Related Experiment Video

Updated: Aug 9, 2025

RhoC GTPase Activation Assay
09:58

RhoC GTPase Activation Assay

Published on: August 22, 2010

12.5K

The Dual Function of RhoGDI2 in Immunity and Cancer

Mudrika Tripathi1, Alain Colige1, Christophe F Deroanne1

  • 1Laboratory of Connective Tissues Biology, GIGA-Cancer, University of Liège, 4000 Liège, Belgium.

International Journal of Molecular Sciences
|February 25, 2023
PubMed

Insights

Rho guanine nucleotide dissociation inhibitor 2 (RhoGDI2) has a dual role in cancer and immunity. This review explores its complex functions and regulatory mechanisms in these critical biological processes.

Area of Science:

  • Molecular Biology
  • Immunology
  • Oncology

Background:

  • RhoGDI2 is a guanine nucleotide dissociation inhibitor (GDI) specific to Rho GTPases.
  • It is expressed in various cell types, notably hematopoietic cells.
  • RhoGDI2 is linked to human cancers and immune system regulation, exhibiting a dual role.

Purpose of the Study:

  • To elucidate the dual and opposing roles of RhoGDI2 in cancer.
  • To highlight the underappreciated functions of RhoGDI2 in immunity.
  • To propose explanations for the complex regulatory mechanisms of RhoGDI2.

Main Methods:

  • Literature review and synthesis of existing research on RhoGDI2.
  • Analysis of studies investigating RhoGDI2's involvement in cancer.
  • Examination of research focusing on RhoGDI2's role in immune regulation.

Main Results:

  • RhoGDI2 exhibits context-dependent pro- and anti-cancer activities.
  • RhoGDI2 plays a significant, yet often overlooked, role in modulating immune responses.
  • The precise mechanistic functions of RhoGDI2 remain incompletely understood.

Conclusions:

  • RhoGDI2 possesses a complex, dual role in cancer, acting as both a tumor suppressor and promoter.
  • RhoGDI2 is a key regulator in immunity, influencing various immune cell functions.
  • Further research is needed to fully unravel the intricate regulatory functions of RhoGDI2.
Keywords:
Rho GTPases 3RhoGDI1 2RhoGDI2 1cancer 4immunity 5

More Related Videos

Author Spotlight: Dendritic Cells Maturation Using Sialidases-Based Enzymatic Treatment of the Cell Surface13:36

Author Spotlight: Dendritic Cells Maturation Using Sialidases-Based Enzymatic Treatment of the Cell Surface

Published on: October 20, 2023

3.6K
Affinity Precipitation of Active Rho-GEFs Using a GST-tagged Mutant Rho Protein GST-RhoAG17A from Epithelial Cell Lysates11:28

Affinity Precipitation of Active Rho-GEFs Using a GST-tagged Mutant Rho Protein GST-RhoAG17A from Epithelial Cell Lysates

Published on: March 31, 2012

16.6K

Related Concept Videos

Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
4.0K
Cell Polarization by Rho Proteins01:21

Cell Polarization by Rho Proteins

Cell polarity is the asymmetric distribution of cellular and membrane components, making one side of the cell different from the other. This polarity is essential to many processes such as embryogenesis, axon migration, glucose transport across epithelial cells, and directional cell migration. A migrating cell responds to intracellular or extracellular signals via molecular cascades that reorganize the actin cytoskeleton to establish this polarity. In these cells, the Rho family proteins Cdc42,...
2.7K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
6.3K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.3K
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.2K
Psychoneuroimmunology: Diabetes and Cancer01:19

Psychoneuroimmunology: Diabetes and Cancer

Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
53